Skip to main content
. 2023 Nov 16;11(32):7814–7821. doi: 10.12998/wjcc.v11.i32.7814

Table 2.

Primary outcome and its components

Outcome
Aspirin group (n = 30)
No aspirin group (n = 30)
Relative risk (95%CI)
P value
Primary outcome, n (%) 2 (6.7) 5 (16.7) 0.40 (0.12-1.31)
Recurrent stroke, n (%) 1 (3.3) 3 (10) 0.33 (0.04-2.76) 0.31
Myocardial infarction, n (%) 1 (3.3) 1 (3.3) 1.00 (0.07-14.42) 1.00
Vascular death, n (%) 1 (3.3) 2 (6.7) 0.50 (0.05-4.79) 0.55

95%CI: 95% confidence interval.